| FCASX | RIDAX | FCASX / RIDAX | |
| Total Expense Ratio | 1.67 | 1.34 | 125% |
| Annual Report Gross Expense Ratio | 1.70 | 1.34 | 127% |
| Fund Existence | 17 years | 24 years | - |
| Gain YTD | 17.394 | 8.784 | 198% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.71B | 140B | 6% |
| Annual Yield % from dividends | 0.64 | 2.82 | 23% |
| Returns for 1 year | 12.68 | 8.07 | 157% |
| Returns for 3 years | 37.97 | 24.61 | 154% |
| Returns for 5 years | 26.02 | 24.14 | 108% |
| Returns for 10 years | 76.05 | 46.58 | 163% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GSRLX | 11.96 | 0.05 | +0.42% |
| Goldman Sachs Rising Dividend Gr Instl | |||
| REGRX | 20.89 | 0.06 | +0.29% |
| Russell Inv Emerging Markets R6 | |||
| GSPQX | 18.30 | 0.05 | +0.27% |
| Goldman Sachs US Eq Div and Premium C | |||
| TRBCX | 213.17 | 0.44 | +0.21% |
| T. Rowe Price Blue Chip Growth | |||
| EUGAX | 27.02 | 0.01 | +0.04% |
| Morgan Stanley Europe Opportunity A | |||